Kibow Biotech Receives AwardKibow Biotech Receives Award
Kibow Biotech, Inc. received the 2014 BIO International Convention “Buzz of BIO" award, the first biotechnology company specializing exclusively in dietary supplement products to receive the honor in BIO’s 29-year history.
June 17, 2014
NEWTOWN SQUARE, Pa.—Kibow Biotech, Inc. received the 2014 BIO International Convention “Buzz of BIO" award, the first biotechnology company specializing exclusively in dietary supplement products to receive the honor in BIO’s 29-year history. BIO is a trade association, representing biotechnology companies, academic institutions, state biotechnology centers, and related organizations across the United States and more than 30 other nations. BIO member companies are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.
Established in 1997, Kibow Biotech is a wellness company with scientific and research and development (R&D) expertise in probiotic-based and other dietary supplements. Kibow Biotech provides natural solutions for customers hoping to improve their quality of life. Scientifically and clinically-validated, Kibow's wellness products provide customers with safe and effective alternatives: Renadyl™ probiotic for kidney health; Kibow Flora™, a potent probiotic formulation for digestive and immune health; Kibow Fortis™, a multi-prebiotic fiber supplement for digestive health, weight control and glucose balance; and Azodyl®, the natural solution for dogs and cats with kidney failure.
Natarajan Ranganathan, Ph.D., Kibow Biotech cofounder and chief R&D scientist, will present Kibow’s probiotic and prebiotic wellness supplements at the 2014 BIO International Convention, June 23-26 in San Diego. Kibow Biotech's recognition is the result of its earlier selection for a poster presentation, as an Emerging Biotech Company, at the 2007 BIO-Boston Meeting as well as for its novel approach to pharmaceutical-like product validation for "enteric uremic toxin reduction technology" (Enteric Dialysis®).
You May Also Like
The rise of ashwagandha: A case study in a growing and evolving category – articleNov 28, 2023
Ashwagandha: Roots for wellness, leaves for soil – articleNov 28, 2023
Creatine, whey protein, beta-alanine among picks in NFL-style draft at SupplySide WestDec 01, 2023
Unleash the power of ‘combos’ supplements to meet consumer demand – infographicNov 22, 2023